0001857448-26-000002.txt : 20260814 0001857448-26-000002.hdr.sgml : 20260814 20260814131826 ACCESSION NUMBER: 0001857448-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260814 DATE AS OF CHANGE: 20260814 EFFECTIVENESS DATE: 20260814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Maxona Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001857448 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-548944 FILM NUMBER: 261279220 BUSINESS ADDRESS: STREET 1: 101 LINDENWOOD DRIVE STREET 2: SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484.681.5626 MAIL ADDRESS: STREET 1: 101 LINDENWOOD DRIVE STREET 2: SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 D/A 1 primary_doc.xml X0708 D/A LIVE 0001857448 Maxona Pharmaceuticals, Inc. 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 484.681.5626 DELAWARE None None Corporation true Shahin Fatholahi 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Behshad Sheldon 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Director David Nakamura 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Director Richard Brand 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001857448-25-000002 2025-06-04 true true false 0 Arcadia Securities, LLC 44656 None None 1370 Avenue of the Americas, 29th Floor New York NY NEW YORK 10019 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS NE NEBRASKA NV NEVADA NY NEW YORK NC NORTH CAROLINA OK OKLAHOMA PA PENNSYLVANIA RI RHODE ISLAND TN TENNESSEE TX TEXAS WI WISCONSIN false 12000000 5778673 6221327 false 56 412064 0 1000000 true false Maxona Pharmaceuticals, Inc. /s/ Shahin Fatholahi Shahin Fatholahi Chief Executive Officer 2026-08-13